Regenerative Medicine and Stem Cells Technologies

Mast cells are critically involved in immunity and immune disorders. However, they are rarely cultured ex vivo for experimental manipulation because of the difficulty in isolating useful numbers and limitations related to 2-D culture. A new study reports the successful development of authenticated mast cells by culturing hematopoietic stem cells in an engineered 3-D connective tissue matrix. The work is published in Tissue Engineering.

Scientists studying one of the most common forms of childhood cancer have made an important breakthrough in understanding how the disease progresses.

The challenges of student stem cells and regenerative medicine research centers of Alborz, Kerman, and Fars provinces were held in the presence of managers of education and research centers of provinces to develop the knowledge of stem cells in students and eliminate their problems.

This January, Turkey will host the vice president for science and technology affairs of Iran and a business delegation. A delegation of knowledge-based companies that are active in different scientific and technological fields will travel to Turkey to introduce their capabilities.

The vice president for science and technology affairs emphasized that combatting the smuggling of goods and currencies requires domestic methods, stating: the software, systems and establishments for combatting the smuggling of goods and currencies must be domestic in the country and based on domestic belongings, such as the abilities of knowledge-based companies and startups.

The nanotechnology platform, which uses special tiny rods for sensing, allows researchers to confirm the identity of human stem cell fates and their biomarkers, or biological molecules, without destroying them, according to a study in ACS Nano. Thats been a major issue during pre-clinical research on stem cells because it limits further analyses and biomedical applications.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the United Kingdom’s (UK) Medicines Healthcare Products Regulatory Agency (MHRA) has granted authorization of the first-in-human clinical trial to evaluate a Chimeric Antigen Receptor Regulatory T Cell (CAR-Treg) therapy.

Recent research from the laboratory of Alexandra J. Harvey (University of Melbourne, Victoria, Australia) established that induced pluripotent stem cells (iPSCs) fail to modulate carbohydrate and amino acid utilization in response to oxygen [1] when compared to embryonic stem cells (ESCs) or preimplantation embryos.

A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders.

Research conducted aboard the International Space Station will look at how nerve cells interact with key immune cells of the brain in low-gravity conditions. The goal is to better understand nervous system damage in Parkinson’s disease and multiple sclerosis (MS) — and help improve their treatments.